7 Essential Security Controls for Cardiac Device Compliance

Last updated: July 13, 2026

Key Takeaways for Cardiac Report Security in 2026

  • Cardiac device report automation platforms must embed seven essential security controls: encryption, RBAC, SBOM, audit logging, zero-trust access, redundant feeds, and CPT documentation integrity to satisfy HIPAA, FDA, IEC 62304, SOC 2, and Section 524B at the same time.
  • The FDA’s February 2026 premarket cybersecurity guidance and Section 524B of the FD&C Act together make SBOM submission, coordinated vulnerability disclosure, and postmarket patch management statutory requirements for any connected cardiac report automation platform.
  • IEC 62304 and SOC 2 Type II together require full software-lifecycle traceability, risk-management integration, immutable audit logs, and independently verified controls covering security, availability, and confidentiality.
  • Multi-OEM data normalization through API, HL7, XML, and AI-powered PDF parsing, combined with redundant fail-safe feeds, maintains >99.9% transmissibility while preserving encryption, RBAC, and audit integrity across every ingestion path.
  • Rhythm360 delivers all seven controls in a single vendor-neutral dashboard; schedule a demo to see how the platform maps these requirements to your practice’s CIED and RPM workflows.

How FDA Premarket and Postmarket Rules Shape CIED Report Automation

On February 3, 2026, the FDA reissued its cybersecurity premarket guidance, aligning it with the new Quality Management System Regulation (QMSR) under 21 CFR Part 820, which incorporates ISO 13485:2016. For cardiac device report automation platforms, cybersecurity now functions as a statutory design requirement rather than an optional enhancement.

Premarket checklist for CIED report automation vendors:

  • Documented Secure Product Development Framework (SPDF) using AAMI TIR45, IEC 81001-5-1, or ANSI/ISA 62443-4-1
  • Security architecture views covering global system, multi-patient harm, updateability, and security use cases
  • Threat modeling using STRIDE with traceability to ISO 14971 clinical harm scenarios
  • Machine-readable SBOM in SPDX or CycloneDX format listing all components, versions, and end-of-support dates
  • Coordinated Vulnerability Disclosure (CVD) plan submitted with the premarket package
  • Penetration testing, fuzz testing, static and dynamic code analysis results with documented mitigation traceability
  • Postmarket cybersecurity management plan with patch SLOs and expedited cycles for critical vulnerabilities

Rhythm360’s architecture maps directly to these requirements. Multi-OEM data ingestion via API, HL7, and XML feeds follows documented data flow diagrams and trust boundaries. Bi-directional EHR integration with Epic, Cerner, Athenahealth, and others uses mutual TLS and X.509 certificate-based authentication, satisfying FDA minimum encryption standards of AES-256 at rest and TLS 1.3 in transit. Postmarket vulnerability monitoring feeds into Rhythm360’s corrective and preventive action processes, consistent with FDA’s December 2016 postmarket cybersecurity guidance, which remains in force alongside the 2026 premarket update.

Rhythm360
Rhythm360

How Section 524B of the FD&C Act Applies to Cardiac Report Automation

While the FDA’s premarket guidance sets design and documentation expectations, Section 524B of the FD&C Act makes specific cybersecurity elements statutory and mandatory, with non-compliance classified as a prohibited act under Section 301(q). Any cardiac report automation platform that connects to OEM device networks, EHRs, or cloud infrastructure qualifies as a cyber device within this framework.

Section 524B compliance checklist:

  • SBOM submitted with every premarket application, enumerating all software components with version numbers, suppliers, dependency relationships, and end-of-support dates so practices can predict patch coverage
  • SBOM entries cross-referenced against the CISA Known Exploited Vulnerabilities Catalog to reveal current exposure before procurement
  • Software support level and end-of-support dates documented for every SBOM component to clarify long-term maintenance
  • Formal postmarket cybersecurity management plan addressing regular and expedited patch cycles
  • SBOMs made available to customers upon demand per Health-ISAC guidance
  • Connectivity features and device support lifetime disclosed in cybersecurity labeling

Rhythm360’s SBOM practices cover every software component involved in multi-OEM data normalization, including upstream dependencies in the AI-powered PDF parsing and computer-vision layers. This transparency extends to EHR integration modules, helping practices that rely on Rhythm360 as a business associate satisfy their own downstream HIPAA and FDA supply chain obligations.

Cybersecurity Expectations for Networked Medical Devices in 2026

In 2026, 84% of healthcare organizations reported embedding cybersecurity requirements into procurement processes, and 56% rejected medical devices due to security concerns, up from 46% in 2025. For cardiac report automation platforms that aggregate data from major CIED manufacturers, networked device security now functions as a procurement requirement rather than a post-implementation check.

Networked device cybersecurity checklist for 2026:

  • Zero-trust architecture enforcing least-privilege access, explicit identity verification, and device health checks at every session
  • Mutual TLS (mTLS) with certificate pinning for all device-to-cloud and app-to-cloud channels
  • Multi-factor authentication on all clinician-facing portals and mobile applications
  • Vulnerability scoring using CVSS or SSVC applied consistently across all security documentation
  • Attack surface analysis, closed-box vulnerability scanning, and penetration testing performed and documented
  • Cybersecurity metrics maintained in management reviews proportionate to device risk
  • Incident response plan aligned with HIPAA §164.308(a)(6) and SOC 2 CC7.3–CC7.5 with a 60-day breach notification capability

Rhythm360’s secure, HIPAA-compliant mobile application implements zero-trust principles through MFA, certificate-based session authentication, and encrypted data channels. Electrophysiologists and device technicians can review transmissions, sign reports, and coordinate care from any location without weakening the security posture of the broader platform.

How IEC 62304 Shapes Cardiac Device Software Lifecycle

IEC 62304 is recognized by the FDA as a consensus standard for medical device software development and applies to both embedded firmware and standalone Software as a Medical Device (SaMD) running on cloud platforms. Cardiac report automation software that ingests, normalizes, and presents CIED data to clinicians falls within this scope.

IEC 62304 compliance checklist for cardiac report automation:

  • Software safety classification (Class A, B, or C) documented based on potential severity of harm from software failure
  • Software Development Plan (SDP) and Software Requirements Specification (SRS) with unique identifiers for every requirement
  • Full lifecycle traceability linking requirements, architecture, implementation, and verification test cases
  • Integration with ISO 14971 risk management so every software anomaly leading to a clinical hazard links to a control
  • Fault Tree Analysis or FMEA for Class B and C functions such as alert generation and CPT documentation capture
  • Cybersecurity hazards, including unauthorized modification of clinical data and denial-of-service attacks, addressed in every lifecycle phase
  • Post-market surveillance procedures for monitoring vulnerabilities, assessing safety impact, and deploying security updates
  • Software of Unknown Provenance (SOUP) components assessed for functional gaps and monitored for newly disclosed vulnerabilities

Rhythm360’s software lifecycle processes embed IEC 62304 requirements into the platform’s AI-powered alert triage, automated report generation, and EHR synchronization modules. Cybersecurity appears in every IEC 62304 lifecycle phase, from planning through post-market maintenance, which keeps the multi-OEM normalization engine clinically reliable and aligned with current regulatory expectations.

What SOC 2 Compliance Signals for Cardiac Report Automation

SOC 2 Type II is a key cybersecurity standard for medical device manufacturers providing service organization controls for cloud infrastructure. For cardiac report automation platforms, SOC 2 Type II attestation gives practices independently verified evidence that the vendor’s controls for security, availability, and confidentiality meet defined criteria, a requirement that has become standard in healthcare procurement, as noted earlier.

SOC 2 compliance checklist for cardiac report automation vendors:

  • SOC 2 Type II report covering Security (CC6), Availability (A1), and Confidentiality (C1) trust service criteria
  • Quarterly access reviews and timely access termination procedures satisfying SOC 2 CC6.1–CC6.3 and HIPAA §164.312(a)
  • Encryption standards meeting the AES-256/TLS 1.3 baseline established earlier, applied across both SOC 2 and HIPAA Transmission Security controls
  • Immutable audit logs with defined retention periods and unauthorized-activity review processes per SOC 2 CC7.1–CC7.2
  • Incident response procedures with documented 60-day HIPAA breach notification capability per SOC 2 CC7.3–CC7.5
  • Business Associate Agreement (BAA) executed with covered entities, specifying PHI protection obligations and subcontractor flow-down requirements

Rhythm360 operates as a HIPAA-compliant business associate, executing BAAs with every covered entity it serves. The platform’s SOC 2-aligned controls, including RBAC, MFA, audit logging, and encrypted data channels, apply uniformly across all OEM data feeds, EHR integrations, and the Twilio-powered communication hub, so every PHI transfer point follows the same control framework.

Schedule a demo to review Rhythm360’s SOC 2 attestation and HIPAA compliance documentation with your compliance team.

SBOM Expectations in 2026 for Cardiac Device Report Automation

SBOM requirements under Section 524B mandate cataloging every software component with version information and end-of-support dates as a mandatory premarket submission element evaluated in eSTAR format. In April 2026, MITRE released a white paper on challenges in SBOM data normalization, a problem that becomes acute for platforms ingesting data from multiple OEM ecosystems with heterogeneous software stacks.

SBOM expectations checklist for 2026:

  • Machine-readable SBOM in SPDX or CycloneDX format covering all software and firmware components
  • Every SBOM entry includes component name, version, supplier, dependency relationships, and end-of-support date
  • Known vulnerabilities cross-referenced against the CISA Known Exploited Vulnerabilities Catalog at time of submission
  • SBOM maintained and updated throughout the product lifecycle, not only at initial submission
  • SBOM made available to customers upon demand as required by Section 524B
  • SOUP components tracked within the SBOM with continuous monitoring for newly disclosed CVEs
  • SBOM entries for AI and computer-vision components used in PDF parsing and data normalization included and versioned

Rhythm360’s SBOM governance covers the full technology stack involved in multi-OEM data normalization, including the AI-powered extrapolation engine, computer-vision PDF parser, HL7 integration modules, and redundant data feed infrastructure. This end-to-end component transparency helps practices satisfy downstream vendor risk assessment requirements and supports the secure software development program obligations that Health-ISAC identifies as non-negotiable for connected medical device vendors in 2026.

Secure Multi-OEM Data Normalization With High Transmissibility

Cardiac report automation platforms must ingest data from OEMs such as Medtronic, Boston Scientific, Abbott, Biotronik, and others, each using proprietary data formats, portal architectures, and transmission protocols. Normalizing this data into a single, clinically actionable record without PHI exposure or compliance gaps requires a layered technical approach governed by HIPAA, FDA, and SOC 2 controls at the same time.

Rhythm360 maintains high transmissibility through four complementary ingestion methods:

  • API integration: Direct, authenticated connections to OEM platforms using OAuth 2.0 and mutual TLS, with all data encrypted in transit and access governed by least-privilege service accounts
  • HL7 messaging: Bi-directional HL7 feeds to and from EHR systems including Epic, Cerner, Athenahealth, and eClinicalWorks, with message-level audit logging satisfying HIPAA §164.312(b)
  • XML parsing: Structured extraction of device report data from OEM XML exports, normalized against a unified data schema with version-controlled transformation logic
  • Computer-vision PDF parsing: AI-powered optical character recognition (OCR) extracts data from unstructured OEM PDF reports, filling gaps when API or HL7 feeds are unavailable, which prevents missed transmissions during OEM server outages

A redundant data feed architecture acts as a secondary fail-safe. If a primary OEM feed fails, Rhythm360 automatically routes to an alternative ingestion path, maintaining data continuity without manual intervention. All data transfers between remote monitoring portals and downstream systems require encryption, BAAs, and access controls, and Rhythm360 applies these controls uniformly across every ingestion method. The result is a single, normalized patient record that supports clinical decision-making and auditable CPT documentation for codes including 93298, 93299, and 99454.

10-Item Vendor-Evaluation Checklist for Cardiac Device Report Automation Platforms

This 10-item checklist gives practices a structured framework for assessing data security compliance against the 2026 regulatory stack.

#Evaluation CriterionWhat to VerifyScore (1–5)
1Encryption standardsAES-256 at rest and TLS 1.3 in transit confirmed in security documentation
2RBAC and MFALeast-privilege roles, quarterly access reviews, and MFA enforced on all user interfaces including mobile
3SBOM availabilityMachine-readable SBOM in SPDX or CycloneDX format available upon demand per Section 524B
4Audit loggingImmutable logs of all PHI access, report generation, and CPT documentation events with defined retention periods
5Zero-trust mobile accessCertificate-based authentication, mTLS, and MFA on clinician-facing mobile application
6Redundant data feedsDocumented fail-safe ingestion paths maintaining >99.9% transmissibility during OEM outages
7CPT documentation integrityAutomated, auditable capture of CIED and RPM CPT codes with EHR-integrated documentation trail
8SOC 2 Type II attestationCurrent SOC 2 Type II report covering Security, Availability, and Confidentiality trust service criteria
9Single vendor-neutral dashboardAll OEM device data from supported manufacturers consolidated into one normalized view without requiring separate portal logins
10Optional 24/7 CCT oversightCertified cardiac technicians supervised by physicians available around the clock for alert triage and intervention support

Rhythm360 is designed to score at the highest level across all ten criteria. The platform’s vendor-neutral dashboard removes the need for separate OEM portal logins, and its optional 24/7 CCT oversight layer provides physician-supervised triage coverage that can reduce critical alert response times by up to 80%.

Frequently Asked Questions

Required Encryption Standards for Cardiac Report Automation in 2026

A compliant platform must apply AES-256 encryption to all PHI stored at rest and TLS 1.3 for all data transmitted between OEM portals, the automation platform, and EHR systems. These standards satisfy both HIPAA’s Transmission Security requirements under §164.312(e) and FDA’s 2026 premarket cybersecurity guidance minimum encryption expectations. Rhythm360 applies encryption across every data ingestion method, including API, HL7, XML, and computer-vision PDF parsing, and across all EHR integration channels.

How Section 524B Affects Cardiac Data Aggregation Platforms

Section 524B applies directly to manufacturers of cyber devices submitting premarket applications. Cardiac report automation platforms that connect to OEM networks, cloud infrastructure, and EHR systems still appear in the broader supply chain evaluation under FDA SBOM and postmarket cybersecurity management requirements. Covered entities relying on these platforms as business associates must verify that the vendor maintains an SBOM, a coordinated vulnerability disclosure plan, and a postmarket patch management process, and practices should confirm these elements through vendor due diligence before contracting.

IEC 62304 and Cloud-Based Cardiac Report Automation

IEC 62304 applies to standalone Software as a Medical Device running on cloud platforms, which includes cardiac report automation software that generates clinically actionable reports from CIED data. The standard requires software safety classification based on potential harm from failure, full lifecycle traceability from requirements through verification, integration with ISO 14971 risk management, and post-market surveillance procedures for vulnerability monitoring and security updates. For Class B or C functions, such as alert generation for ventricular tachycardia or CPT documentation capture, the standard also requires Fault Tree Analysis or FMEA and exhaustive unit testing.

What SOC 2 Type II Attestation Means for Remote Monitoring Vendors

SOC 2 Type II attestation means an independent auditor has tested the vendor’s security controls over a defined period, typically six to twelve months, and confirmed that those controls operated effectively. For cardiology practices, this provides verified evidence that the vendor’s RBAC, encryption, audit logging, and incident response procedures function as documented. SOC 2 CC6.1–CC6.3 controls map directly to HIPAA §164.312(a) access control requirements, so a current SOC 2 Type II report substantially supports a practice’s own HIPAA risk management documentation. Practices should request the full report, not just a summary, and verify that the audit period is current.

Compliance Risks in Multi-OEM Data Normalization and How to Reduce Them

Each OEM portal, including platforms from major CIED manufacturers, uses proprietary data formats and transmission protocols. When staff manually retrieve and re-enter data across these portals, every transfer point introduces risk of unauthorized disclosure, transcription error, and incomplete audit trails. Automated normalization through API, HL7, XML, and AI-powered PDF parsing removes manual re-entry, but only when the normalization layer itself follows encryption, RBAC, immutable audit logging, and SBOM-tracked software components. Practices should verify that a vendor’s normalization engine appears in its SOC 2 attestation and HIPAA BAA and that redundant feed architecture prevents data gaps during OEM outages.

Conclusion: Turning Compliance into Faster Care and Protected Revenue

The 2026 regulatory environment for cardiac device report automation software requires practices to evaluate vendors against a complete compliance stack that includes HIPAA encryption and audit controls, FDA premarket and postmarket cybersecurity obligations, Section 524B SBOM requirements, IEC 62304 software lifecycle processes, and SOC 2 Type II attestation. Fragmented OEM portals and manual workflows cannot satisfy this stack, and non-compliance can trigger OCR civil money penalties, breach notification obligations, missed critical alerts, and lost CPT revenue.

Rhythm360 embeds all seven essential security controls, including encryption, RBAC, SBOM, audit logging, zero-trust mobile access, redundant data feeds, and CPT documentation integrity, into a single vendor-neutral dashboard that normalizes data from every major CIED manufacturer. The platform turns compliance into faster care and protected revenue, reducing critical alert response times by up to 80% and supporting revenue improvements of up to 300% through auditable CPT documentation.

Schedule a demo to see how Rhythm360’s 2026 compliance architecture maps to your practice’s specific OEM mix, EHR environment, and regulatory obligations.

Advisory Tags
Our automatic tagging and tracking keeps getting better - identify, manage and track multiple advisories more efficiently.
View and Acknowledge Recalls
Staff can document steps taken to resolve the recall for continuity of communication, tracking, and accountability.
Links Straight to FDA
Rhythm360 provides direct access to all the advisory details you need without additional searching and clicks.